Table 3.
Fatigue
| |
Patients |
Controls |
||
|---|---|---|---|---|
| Fatigue < = 4 | Fatigue > 4 | Fatigue < = 4 | Fatigue > 4 | |
| Respondents 1166 |
349 (30%) |
817 (70%) |
17 (25%) |
51 (75%) |
| Age |
62.8 |
64.5 |
60.1 |
60.3 |
| Disease duration (years) |
18.1 |
19.5 |
- |
- |
| Working (%) |
24.3% |
20.0% |
33% |
59% |
| % on Biologics |
45.5% |
39.9% |
- |
- |
| HAQ |
0.8 |
1.4* |
- |
- |
| Disease activity |
3.1 |
5.3* |
- |
- |
| Global health (VAS) |
3.4 |
4.9* |
2.9 |
4.0 |
| Pain (VAS) |
3.1 |
5.4* |
- |
- |
| Mood (VAS) |
3.1 |
4.7* |
3.2 |
4.0 |
| Utility | 0.70 | 0.48* | 0.69 | 0.63 |
*p < 0.01 high versus low fatigue.
All VAS including fatigue = 1(best)-10(worst); Utility 0(death)-1(full health); HAQ = Health Assessment Questionnaire.